Liver injuries induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry;Hepatotoxicidad secundaria a "productos naturales": Análisis de los casos notificados al Registro Español de Hepatotoxicidad

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 11, 2008, Pages 688-695

  Garcia Cortes M ^a,j   Borraz, Y ^b,j   Lucena, M I ^b,j   Pelaez G ^c   Salmeron J ^d,j   Diago, M ^e   Martinez Sierra M C ^f   Navarro, J M ^g   Planas, R ^h,j   Soria, M J ^f   Bruguera, M ^i,j   Andrade, R J ^a,j,k  

^a Facultad de Medicina   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL TORRECÁRDENAS   (Spain)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^g HOSPITAL COSTA DEL SOL   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

^k UNIVERSIDAD DE MÁLAGA   (Spain)

more..

Author keywords

Hepatotoxicity; Natural remedies; Productos herbals; Reacciones adversas hep ticas

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; CASCARA SAGRADA; HERBACEOUS AGENT; ISOFLAVONE DERIVATIVE; NEUROLEPTIC AGENT; GREEN TEA EXTRACT AR25; PLANT EXTRACT; PLANT MEDICINAL PRODUCT;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HERBAL MEDICINE; HUMAN; HYPERSENSITIVITY; JAUNDICE; LIVER CELL DAMAGE; LIVER INJURY; LIVER TOXICITY; MALE; OUTCOME ASSESSMENT; TEA; ADULT; AGED; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG EFFECT; INTRAHEPATIC CHOLESTASIS; LIVER CELL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYTOTHERAPY; RECURRENT DISEASE; REGISTER; SPAIN; STATISTICS; TOXIC HEPATITIS;

ADULT; AGED; CAMELLIA SINENSIS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HEPATITIS, TOXIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PREPARATIONS; RECURRENCE; REGISTRIES; SPAIN; YOUNG ADULT;

EID: 63149154371     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Wheaton AG, Blanck HM, Gizlice Z, Reyes M. Medicinal herb use in a population-based survey of adults: prevalence and frequency of use, reasons for use, and use among their children. Ann Epidemiol 2005; 15: 678-85.
2. Kim S, Hohrmann JL, Clark S, Munoz KN, Braun JE, Doshi A, et al. A multicenter study of complementary and alternative medicine usage among ED patients. Acad Emerg Med 2005; 12: 377-80.
3. Kennedy J. Herb and supplement use in the US adult population. Clin Ther2005;27: 1847-58.
4. Sanfelix J, Palop V, Rubio E, Martínez I. Consumo de hierbas medi-cinales y medicamentos. Atención Primaria 2001; 28: 311-4.
5. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286: 208-16.
6. Matthews HB, Lucier GW, Fisher KD. Medicinal herbs in the United States: research needs. Environ Health Perspect 1999; 107: 773-8.
7. Norris W, Paredes AH, Lewis JH. Drug-induced liver injury in 2007. Curr Opin Gastroenterol 2008; 24: 287-97.
8. Danan G, Benichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meeting: application to drug-induced liver injures. J Clin Epidemiol 1993; 43: 1323-30.
9. Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model or validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6.
10. Benichou C. Report of an International Consensus Meeting. Criteria of drug-induced liver disorders. J Hepatol 1990; 11: 272-6.
11. Gavilan JC, Bermudez FJ, Salgado F, Peña D. Phytotherapy and hepatitis. Rev Clin Esp 1999; 199: 693-4.
12. Bruguera M, Herrera S, Lazaro E, Madurga M, Navarro M, De Aba-jo FJ. Hepatitis aguda asociada al consumo de Copalchi. A proposito de 5 casos. Gastroenterol Hepatol 2007; 30: 66-8.
13. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005; 43: 901-10.
14. Andrade RJ, Lucena MI, García-Cortés M. Hepatotoxicity due to herbal infusion. Gastroenterol Hepatol 2002; 25: 327-32.
15. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
16. Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003; 138: 852-8.
17. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26(Supl. 1): 47-51.
18. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27: 465-74.
19. Jorge OA, Jorge AD. Hepatotoxicidad asociada al consume de Cen-tella Asiatica. Rev Esp Enferm Dig 2005; 97: 115-24.
20. Edwards R. Monitoring the safety of herbal remedies. WHO project is under way. BMJ 1995; 311: 1569-70.
21. Andrade RJ, Lucena MI, Fernandez MC, Peláez G, Pachkoria K, García-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-21.
22. Schoepfer AM, Engel A, Fattinger K, Marbet UA, Criblez D, Rei-chen J, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatol 2007; 47: 521-6.
23. Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol 2007; 47: 514-20.
24. Stickel F. Slimming at all costs: herbalife-induced liver injury. J Hepatol 2007; 47: 444-6.
25. Duque JM, Ferreiro J, Salgueiro E, Manso G. Hepatotoxicity associated with the consumption of herbal slimming products. Med Clin (Barc) 2007; 128: 238-9.
26. Manso G, López-Rivas L, Duque JM, Salgueiro E. Spanish reports of hepatotoxicity associated with Herbalife® products. J Hepatol 2008; 49: 289-90.
27. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262-8.
28. Herrera S, Bruguera M. Hepatotoxicidad inducida por el uso de hierbas y medicamentos para perder peso. Gastroenterol Hepatol 2008; 31: 447-53.
29. Fernández-Castañer A, García-Cortés M, Lucena MI, Borraz Y, Peláez G, Costa J, et al. Análisis de las causas, características y consecuencias de la reexposición al fármaco o compuesto responsable de un episodio de hepatotoxicidad. Rev Esp Enferm Dig 2008; 100: 278-84.
30. Andrade RJ, Robles M, Ortiz N, Lucena MI. Reexposición en hepatotoxicidad: ¿prueba de concepto o accidente terapéutico? Rev Esp Enferm Dig 2008; 100: 255-8.
31. Federico A, Tiso A, Loguercio C. A case of hepatotoxicity caused by green tea. Free Radic Biol Med 2007; 43: 474.
32. Bjornsson E, Olsson R. Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol 2007; 47: 295-7.
33. Jimenez-Saenz M, Martinez-Sanchez M. Acute hepatitis associated with the use of green tea infusions. J Hepatol 2006; 44: 616-7.
34. Martinez-Sierra MC, Rendon P, Martín Herrera L. Hepatitis aguda tras la ingestion de té verde. Med Clin (Barc) 2006; 127: 119.
35. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006; 144:68-71.
36. Molinari M, Watt KD, Kruszyna T, Nelson R, Walsh M, Huang WY. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl 2006; 12: 1892-5.
37. Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salame E, et al. Fulminant hepatitis during self-medication with hy-droalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005; 17: 1135-7.
38. Abu el Wafa Y, Benavente Fernandez A, Talavera Fabuel A, Perez Ramos MA, Ramos-Clemente JI. Acute hepatitis induced by Camellia sinensis (green tea). An Med Interna 2005; 22: 298.
39. Garcia-Moran S, Saez-Royuela F, Gento E, Lopez Morante A, Arias L. Acute hepatitis associated with Camellia thea and Orthosiphon stamineus ingestion. Gastroenterol Hepatol 2004; 27: 559-60.
40. Vial T, Bernard G, Lewden B, Dumortier J, Descotes J. Acute hepatitis due to Exolise, a Camellia sinensis-derived drug. Gastroenterol Clin Biol 2003; 27: 1166-7.
41. Pedros C, Cereza G, Garcia N, Laporte JR. Liver toxicity of Camellia sinensis dried etanolic extract. Med Clin (Barc) 2003; 121: 598-9.
42. Dueñas Sadornil C, Fabregas Puigtio S, Durandez R. Hepatotoxicity due to Camellia sinensis. Med Clin (Barc) 2004; 122: 677-8.
43. Jones FJ, Andrews AH. Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol 2007; 102: 2357-8.
44. Nota informativa de la Agencia Española del Medicamento: Suspensión de la comercialización de la especialidad farmacéutica Exolise: extracto etanólico de Camelia sinensis (té verde). Ref. 2003/03.
45. Nadir A, Reddy D, Van Thiel DH. Cascara sagrada-induced intrahe-patic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000; 95: 3634-7.
46. Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol 2000; 20: 84-9.
47. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 1998; 123: 1410-4.
48. Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with Kava, a herbal remedy for anxiety. BMJ 2001; 322: 139.
49. Kraft M, Spahn TW, Menzel J, Senninger N, Dietl KH, Herbst H, et al. Fulminant liver failure after administration of the herbal antide-pressant Kava-Kava. Dtsch Med Wochenschr 2001; 126: 970-2.
50. Bujanda L, Palacios A, Silvarino R, Sanchez A, Munoz C. Kavainduced acute icteric hepatitis. Gastroenterol Hepatol 2002; 25: 434-5.
51. Campo JV, McNabb J, Perel JM, Mazariegos GV, Hasegawa SL, Reyes J. Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry 2002; 41: 631-2.
52. Wooltorton E. Herbal kava: reports of liver toxicity. CMAJ 2002; 166: 777.
53. Stickel F, Baumuller HM, Seitz K, Vasilakis D, Seitz G, Seitz HK, et al. Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepa-tol 2003; 39: 62-7.
54. Russmann S, Barguil Y, Cabalion P, Kritsanida M, Duhet D, Lauter-burg BH. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 2003; 15: 1033-6.
55. Teschke R, Gaus W, Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 2003; 10: 440-6.
56. Humberston CL, Akhtar J, Krenzelok EP. Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol 2003; 41: 109-13.
57. Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2003; 178: 442-3.
58. Brauer RB, Stangl M, Stewart JR, Pfab R, Becker K. Acute liver failure after administration of herbal tranquilizer kava-kava (Piper methysticum). J Clin Psychiatry 2003; 64: 216-8.
59. Thomsen M, Vitetta L, Schmidt M, Sali A. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 2004; 180: 198-9.
60. Clouatre DL. Kava kava: examining new reports of toxicity. Toxicol Lett 2004; 150: 85-96.
61. Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991; 337: 372-3.
62. Seybold U, Landauer N, Hillebrand S, Goebel FD. Senna-induced hepatitis in a poor metabolizer. Ann Intern Med 2004; 141: 650-1.
63. Sonmez A, Yilmaz MI, Mas R, Ozcan A, Celasun B, Dogru T, et al. Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation. Acta Gastroenterol Belg 2005; 68: 385-7.
64. Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hant-son P. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39: 1353-7.
65. Hattori M, Namba T, Akao T, Kobashi K. Metabolism of sennosides by human intestinal bacteria. Pharmacology 1988; 36: 172-9.
66. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ 1989; 299: 1156-7.
67. Takegoshi K, Tohyama T, Okuda K, Suzuki K, Ohta G. A case of Venoplant-induced hepatic injury. Gastroenterol Jpn 1986; 21: 62-5.
68. Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 366-73.
69. Lucena MI, Andrade RJ. Incrementando la detectión de reacciones hepatotóxicas en la práctica clinica: un compromiso de calidad. Rev Esp Enferm Dig 2005; 97: 145-53.
70. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007; 11: 577-96.
71. Aithal GP. When is a herb a drug? Eur J Gastroenterol Hepatol 2005; 17: 391-3.
72. Lopez-Cepero JM, Lerma S, Fernandez MD, Amaya A. Hepatotoxi-cidad grave asociada al consumo de Noni (Morinda Citrifolia). Rev Esp Enferm Dig 2007; 99: 179-81.
73. López-Cepero JM, Fernández MD, Ferré A. Réplica. El zumo de Tahitian Noni no es hepatotóxico: nuestros comentarios. Rev Esp Enferm Dig 2007; 99: 730-41.